Latest News

Dupilumab sBLA Submission for COPD Accelerated Based on Second Positive Phase 3 Trial Findings image credit   ©alesmunt/stock.adobe.com
Dupilumab sBLA Submission for COPD Accelerated Based on Second Positive Phase 3 Trial Findings

November 27th 2023

Dupilumab reduced COPD exacerbations by more than one-third in the phase 3 NOTUS trial, matching outcomes from the earlier BOREAS study this year.

Paxlovid Associated with Virologic Rebound in One in Five Patients with Severe COVID-19 Infection image credit paxlovid ©Mike Mareen / stock.adobe.com
Paxlovid Associated with Virologic Rebound in One in Five Patients with Severe COVID-19 Infection

November 16th 2023

Daily Dose: Global Disparities in Asthma Prevalence / image credit: ©New Africa/AdobeStock
Daily Dose: Global Disparities in Asthma Prevalence

November 13th 2023

The Global Burden of Asthma Prevalence on Specific Subgroups  / image credit asthma concept ©Visual Generation/stock.adobe.com
Low Estimated Burden of Asthma in Low- and Middle-Income Countries Likely Reflects Underdiagnosis, Underreporting

November 6th 2023

Hydrocortisone Bests Other Corticosteroids for Community-Acquired Pneumonia in New Analysis / Image credit: ©Crystal Light/AdobeStock
Hydrocortisone Bests Other Corticosteroids for Community-Acquired Pneumonia in New Analysis

October 23rd 2023

Latest CME Events & Activities

2023 IASLC North America Conference on Lung Cancer Satellite Symposia

Register Now!

Burst CME™ - Part I – Overview of Pathophysiology, Diagnosis, and Management of HER3 Expressing Cancers

View More

Burst CME™ - Part III – Advent of HER3 Targeted Approaches and Rationale in Breast Cancer Care

View More

Burst CME™ - Part II – Advent of HER3 Targeted Approaches and Rationale in NSCLC Care

View More

Show Me Your Care Plan™: Monitoring and Managing Patients With EGFR Exon20 Insertion+ NSCLC

View More

Addressing Healthcare Inequities: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis

View More

Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow

View More

2nd Annual Hawaii Lung: A Multidisciplinary Case-Based Conference™

Register Now!

Addressing Healthcare Inequities™: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis

View More

Community Practice Connections™: 17th Annual New York Lung Cancers Symposium

View More

40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

View More

Community Practice Connections™: 6th Annual Precision Medicine Through Plasma™ – Using Liquid Biopsies in Contemporary Oncology Care

View More

Trekking Through the Latest Updates for ROS1-Targeted Therapies

View More

Mapping Out the Role of Emerging Biomarkers and Testing in NSCLC

View More

Navigating the Latest Data on NTRK-Targeted Therapies

View More

21st Annual Winter Lung Cancer Conference®

Register Now!

Community Practice Connections™: Guidebook for Community Oncology NSCLC Treating Teams to Administer EGFR Exon 20-Targeted Regimens

View More

1st Annual Hawaii Lung: A Multidisciplinary Case-Based Conference™

View More

Advances In™ KRAS Inhibition: Modern Considerations In Targeting KRAS-Mutated Lung, Colorectal, And Pancreatic Cancers

View More

How We Do It™: Integrating Gene Fusion Testing in Oncology Clinics for Patients with NSCLC

View More

Community Practice Connections™: 20th Annual Winter Lung Conference

View More

Medical Crossfire®: Key Strategies to Prioritize Testing and the Evolving Role of Genomic Alterations in Providing Precision NSCLC Care

View More

Breaking Down Biomarkers in Non–Small Cell Lung Cancer: A Case-Based Discussion for the Oncology Nurse

View More

The Top 10 Oncogenic Drivers in NSCLC for 2023: What You Need to Know on Tumor Testing, Targets, and Treatment Strategies to Move the Field Forward

View More

Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines

View More

Engaging the Multidisciplinary Care Team to Optimize Care of Patients With EGFR Mutation–Positive NSCLC: A Lung Cancer Tumor Board

View More

Expanding the Armamentarium of Actionable Mutations in NSCLC: Uncovering the Potential of CEACAM5 as a Therapeutic Target

View More

On-Demand Video Updates from the Annual Oncology Meeting

View More

25th Annual International Lung Cancer Congress®

Register Now!

24th Annual International Lung Cancer Congress®

View More

More News

© 2023 MJH Life Sciences

All rights reserved.